Navigation Links
Gene therapy restores sight

US scientists report they have successfully used gene therapy to restore sight to animals with a rare inherited form of blindness. A team of scientists led by Jean Bennett, at the University of Pennsylvania, reported their success in this month's Nature Genetics.Their experiment involved dogs with Leber congenital amaurosis (LCA), a form of blindness, that also affects human infants and for which there is no treatment.

The disease involves a defect in the genes responsible for the retina's ability to translate light into nerve impulses.// In humans, LCA causes severe rapid onset of blindness, a process which begins before birth so infants are born partially blind.

Bennett's team injected the eyeballs of dogs born with LCA with cells modified to contain the appropriate functional genes which restored the animals' sight.Humans are next"This is a dog model of a human disease," said Dr Jonathon Stone of Sydney University who studies the environmental factors contributing to blindness. "It's impressive that the researchers have shown such a degree of improvement in sight - a several fold increase."

However, Dr Stone told ABC Science Online that applying this work to humans would not be immediate nor straightforward."In the dog, LCA shows a slow progression and so the researchers were able to work with adult dogs," he said. "In humans, any gene therapy would have to occur before birth".

Dr Stone said a further challenge would be identifying the exact genetic defect for LCA. "Different people with LCA have defects in different genes, or different parts of the same gene, and this varies from one continent to another," he said. He was confident, nevertheless, that geneticists could achieve this.


'"/>




Page: 1

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Antioxidants protect health tissue in people undergoing radiation therapy.
3. Distraction therapy found very effective in postoperative patients
4. Acupuncture superseeds massage therapy for short term relief of pain
5. Ovarian cancer in relationship with Hormone therapy
6. New therapy better at increasing bone density
7. Gene therapy - Aim to improve blood flow
8. Heat therapy relieves back pain
9. Radiotherapy helps in colon cancer
10. New therapy for pimples
11. Support therapy helps breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene therapy restores sight

(Date:7/25/2008)... Management to discuss second quarter financial re.../ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today ...riday, August 8 at 8:30 a.m. (ET) to discuss its s...ll report its second quarter 2008 financial,result...same day., To access the conference call by telep...
(Date:7/25/2008)...f certain cleaning products reduces lung function,... , FRIDAY, July 25 (HealthDay News) -- A clean, ...ealth, depending on what type of cleaning and air ...suggests that exposure to cleaning products or air...c compound (VOC) called 1,4 dicholorobenzene (1,4 ...
(Date:7/25/2008)...ALLAS, July 25 /PRNewswire/ -- BeaconEquity.com an... making news today., Investors can view all of th...//BeaconEquity.com/m , Today,s Trade Alerts inclu...ddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK ), N... ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abax...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Beg...all/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI )...unced today that its subsidiary has commenced comm...Capsules USP product in the 40mg,strength from its...tion,with the launch, Watson has 180 days of marke...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2
... has been identified by researchers that help thos...is gene seems to confer a preserving effect upon t...as presented by scientists from the Albert Einstei...sity. December 26, 2006 issue of Neurology publish...
...an holds the hand of a little boy, looking at a ro... area, which was in wreck two years ago, washed aw...m village is exuding life now. Along the innocent-... of Chennai, India, new casurina saplings are knee...
... care is set to boom following expectations of the...ars. // The four per cent increase equates to abou...bated premium of $1,750, will begin in April. The ...include a wide range of medical services including...
...int flavored sweetener, produced naturally by plan...used as an ingredient in chewing gum, toothpaste, ...ist at Agricultural Research Service (ARS) and col...y engineered bacteria, a modified form of Escheric...
Other Medicine News:Health News:You may Live Long and Think Clear With a Variant Gene 2Health News:Tsunami-Hit Coastal Regions Needs More Relief 2Health News:Xylitol To Be Produced By Genetically Engineered E. Coli 2
(Date:7/23/2008)... on IND-Enabling Work with Protein Therapeutics th...ement System, CAMBRIDGE, Mass., July 23 /PRNewswi...t has initiated a corporate growth plan with the,a...utive officer and the,establishment of its headqua...odruff Emlen, M.D., a co-founder of the company wh...
(Date:7/22/2008)...to Discuss Development Plan Completed Successfully... -- Amarin Corporation,plc (NASDAQ: AMRN ) today ...ials at the U.S. Food and Drug Administration (FDA... for the treatment of,hypertriglyceridemia. Follow...o Phase 3 with AMR101 in hypertriglyceridemia., D...
(Date:7/22/2008)...ISCO, Calif., July 22 /- Hyperion,The...ted patient enrollment,in its Phase 1/2 clinical t...nia scavenging effects of HPN-100 (formally called...in patients with urea cycle disorders,(UCD). The c...ourth quarter,of this year., (Logo: http://www.n...
(Date:7/22/2008)... an Individual,s Genetic Risk Based on Clinical Da...Educational Materials, WALTHAM, Mass., July 22 /P... (Amex: ILI ), today announced the launch of an e... for the company,s Heart Health Genetic Test.,The ...nsona(R) Heart Health,Genetic Test by Quixtar/Amwa...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Childrens Hospital of Orange County Chooses RIVA System For Safe and Efficient IV Preparation 11930 1Childrens Hospital of Orange County Chooses RIVA System For Safe and Efficient IV Preparation 11930 2Data from Two Pivotal Trials of AMRIX a New Once Daily Extended Release Muscle Relaxant Presented at the American Academy of Pain Medicine Meeting 3311 1Data from Two Pivotal Trials of AMRIX a New Once Daily Extended Release Muscle Relaxant Presented at the American Academy of Pain Medicine Meeting 3311 2Data from Two Pivotal Trials of AMRIX a New Once Daily Extended Release Muscle Relaxant Presented at the American Academy of Pain Medicine Meeting 3311 3Data from Two Pivotal Trials of AMRIX a New Once Daily Extended Release Muscle Relaxant Presented at the American Academy of Pain Medicine Meeting 3311 4Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 1Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 2Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 3Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 4Technology Transforms Market Research in Pharmaceutical Industry 3309 1Technology Transforms Market Research in Pharmaceutical Industry 3309 2Technology Transforms Market Research in Pharmaceutical Industry 3309 3
...C.--(BUSINESS WIRE)--Jun 12, 2007 - Inspire,Pharma...t,scientists and collaborators related to Inspire ...he European Academy of,Allergology and Clinical Im...eborg, Sweden and at the 30th European Cystic Fibr...16, 2007 in Belek,Turkey., The EAACI Congress inc...
...NDS, Texas--(BUSINESS WIRE)--Jun 11, 2007 - Repros...top-line findings,from its six month study of Proe..., conducted in Europe, enrolled 39,premenopausal w...tudy included three dose levels of Proellex(TM) as...rol was Lucrin(R), a GnRH,agonist also known as Lu...
Other Medicine Technology:Inspire Announces Presentations at Two European Scientific,Conferences 2Inspire Announces Presentations at Two European Scientific,Conferences 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 2Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 4Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 5Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 6
Rotating 360 degrees, 3 mm x 7 mm bite.
Right side cutting.
Backward cutting, 3 mm x 7 mm bite, length of shaft 100 mm, overall length 7 inches.
20 mm. Plastic, methylmethacrylate. Supplied sterile.
Medicine Products: